Sustained-release drug formulations for implantation
AssigneeDainippon Sumitomo Pharma Co., Ltd.
InventorsAkihiko Sano, Masako Kajihara, Hiroo Maeda
Life of this patent
Estimating the term…
Loading patent…
AssigneeDainippon Sumitomo Pharma Co., Ltd.
InventorsAkihiko Sano, Masako Kajihara, Hiroo Maeda
Estimating the term…
The present invention relates to a formulation for implantation having a novel constitution, which accomplishes controlled releases of active ingredients. The formulation comprises one of combinations (a), (b) and (c), as well as a carrier comprising a hydrophobic polymer, wherein the particle combination is dispersed into the carrier: (a) particles comprising an active ingredient, particles comprising a carbonate, and particles comprising a substance which is reacted with the carbonate in an aqueous solution to generate carbon dioxide (substance such as an acid); (b) particles comprising an active ingredient and a carbonate, and particles comprising a substance such as an acid; and (c) particles comprising a carbonate, and particles comprising an active ingredient and a substance such as an acid.
A cured sustained-release formulation for implantation, which comprises a carrier comprising a hydrophobic polymer
A sustained-release formulation for implantation, which comprises a carrier comprising a hydrophobic polymer:
Dependencies are inferred from the claim text.